脂肪肝防治
Search documents
西部脂肪肝防治巡讲赋能基层 天士力公益支持助力健康中国
Zhong Guo Jin Rong Xin Xi Wang· 2025-12-31 11:27
转自:新华财经 自2025年清明在甘肃天水启动以来,由中国医师协会主办、脂肪肝培训项目西北分院承办、天士力医药集团战略公益支持的"肝领未来攀峰对话——党建结 对共建暨西部脂肪肝研究与临床实践新视野系列巡讲活动",已在甘肃多地成功举办9场学术交流及义诊活动,线上线下累计吸引3800人次参与。 活动以党建结对共建为纽带,兰州大学第一医院西站院区副院长、直属党支部书记魏红斌与多家基层医院签订共建协议,通过"资源共享、注重实效、相互 借鉴、携手共赢"的合作机制,开展专科共建、人才共培、资源共享、管理共促、文化共育,搭建活动平台、分享工作资源、交流工作经验、解决实际问 题,推动双方医院(党支部)党建与事业发展良性互动,切实提升基层服务群众健康的能力水平。针对基层医院脂肪肝诊疗经验不足的痛点,巡讲团队整合 消化、内分泌、普外、营养、影像等多学科资源,打破科室壁垒,形成标准化诊疗流程;同时通过义诊活动直接服务患者,有效提升基层早期筛查与干预能 力,搭建起跨区域协作平台。 巡讲期间,数十名来自全国三甲医院的脂肪肝领域知名专家到会指导,围绕《代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)》解读、"脂肪肝的 诊疗进展"" ...
瘦人也会得“脂肪肝”,而且死亡风险更高
Xin Lang Cai Jing· 2025-12-28 02:55
转自:生命时报微信公号 很多人认为,"脂肪肝"是胖人们应该关心的事,其实,一些体重正常甚至偏瘦的人也难以幸免。 一项研究显示,瘦人一旦确诊脂肪肝,带来的损伤会更严重。《生命时报》综合专家观点,解读为什么瘦人也会得脂肪肝,并教你如何给肝脏减脂。瘦人得 脂肪肝更危险这项由北京友谊医院、北京大学等机构联合完成的研究发现,不胖的人也会得脂肪肝,且这类体重正常的脂肪肝患者,其肝脏损伤、肝病死亡 及全因死亡风险显著高于肥胖患者。 多脂肪肝患者在肝功能衰竭和肝硬化并发症前没有任何症状,因此不能因没有症状就轻视脂肪肝。如果体重指数正常人群能做到以下五点,脂肪肝是可以逆 转的。科学控制体重北京大学第一医院感染疾病科主任医师徐京杭表示,对于瘦人的脂肪肝,推荐先进行生活方式干预,以体重减轻3%~5%为目标。虽然 这类患者本身就瘦,但如果不减重,脂肪在肝脏的堆积问题很难得到解决,最好在体重指数正常范围内(18.5~23.9)减重,比如50公斤减2.5公斤,100公斤 减5公斤。减重不能过快,一周最好控制在0.5~1公斤内,如果体内脂肪短时间分解太多,超过肝脏的代谢能力,脂肪肝反而会加重。对于体重正常人群,男 性需要把腰围控制在85厘 ...
央视敲响警钟:脂肪肝比你想象更危险,三七脂肝丸扭转健康困局
Sou Hu Wang· 2025-05-08 02:36
Core Insights - The article highlights the increasing prevalence of fatty liver disease in China, with 1 in 3 adults affected, and a concerning trend of younger patients [1] - Fatty liver is often asymptomatic in its early stages, yet it is linked to serious health issues such as hypertension, diabetes, and various cancers [1] - The transition from moderate to severe fatty liver can lead to liver cirrhosis and significantly higher cancer rates compared to healthy individuals [1] Group 1: Health Risks and Statistics - 90% of fatty liver patients show no early symptoms, making it a silent health risk [1] - Moderate fatty liver can progress to cirrhosis in five years, while severe cases have a higher likelihood of developing into liver cancer [1] - Over half of working professionals tend to neglect their health until symptoms become severe, indicating a need for better awareness and proactive health management [1] Group 2: Treatment and Solutions - Traditional views on managing fatty liver emphasize diet and exercise, but recent findings suggest that many cases are not benign and require serious attention [2] - The article introduces Sanqi Fatty Liver Pills, a traditional Chinese medicine approved for treating fatty liver, which aims to address the root causes rather than just the symptoms [2][3] - The product is based on Yunnan's unique natural plant resources and combines traditional medicine with modern pharmaceutical techniques [3] Group 3: Prevention and Management - A comprehensive approach to liver health is recommended, including regular assessments for individuals over 30 and a structured intervention plan involving Sanqi Fatty Liver Pills and physical activity [4] - The article emphasizes the importance of establishing a "prevent-treat-nurture" cycle for liver health, making it as routine as fitness tracking [4] - The narrative stresses that maintaining liver health is crucial for overall well-being, especially for those in demanding work environments [5]